ANAVEON AG
Biotechnology ResearchBasel, Switzerland11-50 Employees
A start up based in Switzerland that develops biologics to modulate the functions of cytokines and provide substantial therapeutic benefits to cancer patients.
Insights
Recent Expansion Anaveon has recently launched ANV419 in a clinical study, showcasing a commitment to advancing immunotherapy solutions. This development opens up opportunities for partnerships with hospitals and oncology centers looking to participate in cutting-edge cancer treatment trials.
Strategic Personnel Appointment The appointment of Dr. Eduard Gasal as Chief Medical Officer underlines Anaveon's focus on medical expertise. Leveraging this key personnel, sales professionals could explore collaborations with medical institutions seeking guidance from top-tier immunotherapy leaders.
Therapeutic Innovation Anaveon's emphasis on developing therapies for less immunogenic tumors presents a niche market opportunity. Sales representatives can target oncology practices and research facilities specializing in personalized treatments for patients with specific tumor types.
Financial Health & Funding With a revenue range of $0-10M and $120M in funding, Anaveon demonstrates financial stability and growth potential. This positions the company as a reliable partner for investors or pharmaceutical companies seeking innovative oncology ventures.
Competitive Analysis By comparing Anaveon with similar biotech companies like iTeos Therapeutics and AlloVir, sales professionals can highlight Anaveon's unique positioning and market differentiators. This competitive advantage can be leveraged to attract strategic collaborations and investment opportunities.
Similar companies to ANAVEON AG
iTeos Therapeutics
184
$10M$50MApplied Biological Materials
61$10MOrphazyme A/S
108Theradaptive
28$10MAlloVir
51$10M$50MPalleon Pharmaceuticals
29$10MMaaT Pharma
85$10M$50M
ANAVEON AG Tech Stack
ANAVEON AG uses 8 technology products and services including TweenMax, Yoast SEO, reCAPTCHA, and more. Explore ANAVEON AG's tech stack below.
- TweenMaxJavascript Frameworks
- Yoast SEOSearch Engines
- reCAPTCHASecurity
- X-XSS-ProtectionSecurity
- HSTSSecurity
- BootstrapUI Frameworks
- ApacheWeb Servers
- Apache HTTP ServerWeb Servers
Media & News
ANAVEON AG's Email Address Formats
ANAVEON AG uses at least 1 format(s):
| ANAVEON AG Email Formats | Percentage |
| First.Last@anaveon.com | 49% |
| First.Middle@anaveon.com | 1% |
| First.MiddleLast@anaveon.com | 1% |
| First.Last@anaveon.com | 49% |
Frequently Asked Questions
Where is ANAVEON AG's headquarters located?
ANAVEON AG's main headquarters is located at Technologiepark Basel, Hochbergerstrasse 60C Basel, 4057 CH. The company has employees across 2 continents, including EuropeNorth America. What is ANAVEON AG's official website and social media links?
ANAVEON AG's official website is anaveon.com and has social profiles on LinkedIn.How much revenue does ANAVEON AG generate?
As of August 2024, ANAVEON AG's annual revenue reached $1.8M. What is ANAVEON AG's SIC code NAICS code?
ANAVEON AG's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does ANAVEON AG have currently?
As of August 2024, ANAVEON AG has approximately 25 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer: C. H.Chief Medical Officer, Anaveon: E. G.Head Of Biomarkers And Bioanalytics: K. R.. Explore ANAVEON AG's employee directory with LeadIQ.What industry does ANAVEON AG belong to?
ANAVEON AG operates in the Biotechnology Research industry. What technology does ANAVEON AG use?
ANAVEON AG's tech stack includes TweenMaxYoast SEOreCAPTCHAX-XSS-ProtectionHSTSBootstrapApacheApache HTTP Server. What is ANAVEON AG's email format?
ANAVEON AG's email format typically follows the pattern of . Find more ANAVEON AG email formats with LeadIQ. How much funding has ANAVEON AG raised to date?
As of August 2024, ANAVEON AG has raised $120M in funding. The last funding round occurred on Dec 16, 2021 for $120M.When was ANAVEON AG founded?
ANAVEON AG was founded in 2017.
Company Overview
- Headquarters
- Technologiepark Basel, Hochbergerstrasse 60C Basel, 4057 CH
- Website
- anaveon.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2017
- Employees
- 11-50
Media & News
Funding & Financials
- $120M
ANAVEON AG has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $120M.
- $10M
ANAVEON AG's revenue is in the range of $10M
Funding & Financials
- $120M
ANAVEON AG has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2021 in the amount of $120M.
- $10M
ANAVEON AG's revenue is in the range of $10M
Company Leadership
C. H.Chief Scientific Officer- E. G.Chief Medical Officer, Anaveon
K. R.Head Of Biomarkers And Bioanalytics- A. K.Head Of Finance
- S. F. -.Head Of Corporate Affairs & Human Resources
Employee Directory
- S. F. -.Head Of Corporate Affairs & Human Resources
C. W.Senior Director Quality Assurance- P. G.It-Manager
- D. P.Clinical Trial Manager
- J. M.Clinical Trial Leader
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
